C.W. Hu, Y.H. Qiu, A. Ligeralde, A.Y. Raybon, S.Y. Yoo, K.R. Coombes, A.A. Qutub+, S.M. Kornblau+, +co-senior authors (2019) Quantifying Proteomic Heterogeneities and Hallmarks in Acute Myelogenous Leukaemia, Nature Biomedical Engineering, in press. (PDF)

F.W. Hoff, C.W. Hu, A.A. Qutub, Y. Qiu, M.J. Hornbaker, C. Bueso-Ramos, H.A. Abbas, S.M. Post, E.S.J.M., de Bont, S.M. Kornblau (2019) Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics – Clinical Applications 16: e1800133.


F. Hoff, C.W. Hu, Y.H. Qiu, A. Ligeralde, E. de Bont, S.Y. Yoo, A.A. Qutub, T. Horton, S.M. Kornblau (2018) Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia (ALL): Recognition and Therapeutic Guidance, Molecular Cancer Research 16: 1263-1274.

 

F. Hoff, C.W. Hu, Y.H. Qiu, S.Y. Yoo, E. de Bont, H. Mahmud, A.A. Qutub, T. Horton, S.M. Kornblau (2018) Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia (AML) Suggest New Therapeutic Targets, Molecular Cancer Research 16: 1275-1286.

A.D. van Dijk, C.W. Hu, E.S.J.M. de Bont, Y.H. Qiu, F.W. Hoff, S.Y. Yoo, K.R. Coombes, A.A. Qutub, S.M. Kornblau (2018) Histone Modification Patterns using RPPA-based Profiling Predict Outcome in Acute Myeloid Leukemia Patients, Proteomics 18: e1700379.

F.W. Hoff, C.W. Hu, A.A. Qutub, Y. Qiu, E. Graver, G. Hoang, M. Chauhan, E.S.J.M. de Bont, S.M. Kornblau (2018) Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays. Cytotechnology 70: 1529-1535.

 

C.W. Hu, H. Li, A.A. Qutub (2018) Shrinkage Clustering: A Fast and Size-Constrained Algorithm for Biomedical Applications, BMC Bioinformatics 19: 19.

 

C. Lantos, S.M. Kornblau, A.A. Qutub (2018) Quantitative Morphological and Cytological Analyses in Leukemia. In: Hematology: Latest Research & Clinical Advances.

 

C.W. Hu, A.A. Qutub (2018) Proteomics in Acute Myeloid Leukemia. In: Myeloid Leukemia.

 

A. Schultz, S. Mehta, F. Hoff, C.W. Hu, T. Horton, S.M. Kornblau, A.A. Qutub (2017) Identifying Cancer-Specific Metabolic Signatures Using Constraint-Based Models, Pacific Symposium on Biocomputing 22: 485-496.

 

A. Quintás-Cardama, C.W. Hu, A.A. Qutub, Y.H. Qiu, X. Zhang, S. Post, N. Zhang, K. Coombes, S. M. Kornblau (2017) p53 Pathway Dysfunction is Highly Prevalent in Acute Myeloid Leukemia Independent of TP53 Mutational Status, Leukemia 6: 1296-1305.

 

L. Liu, Y. Chang, T. Yang, D.P. Noren, B.L. Long, S.M. Kornblau, A.A. Qutub, J. Ye (2016) Evolution-Informed Modeling Improves Outcome Prediction for Cancers, Evolutionary Applications, 10: 68-76. 

 

C.W. Hu, A.A. Qutub (2016) progenyClust: an R package for Progeny Clustering, The R Journal.

D.P. Noren, B. Long, R. Norel, K. Rhrissorrakrai, K. Hess, C.W. Hu, A. Bisberg, A. Schultz, E. Engquist, L. Liu, E. Lin, G. Chen, H. Xie, G. Hunter, AML DREAM Consortium, T. Norman, S. Friend, G.B. Mills, G. Stolovitzky, S.M. Kornblau, A.A. Qutub (2016) A Crowd Sourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis, PLOS Computational Biology, 12:e1004890. 

C.W. Hu, S.M. Kornblau, J.H. Slater, A.A. Qutub (2015) Progeny Clustering: A Method to Identify Biological Phenotypes, Scientific Reports 5: 12894. (R package available; Highlighted in Health Data Management) 

S.M. Kornblau, A.A. Qutub, H. Yao, H. York, Y. Qiu, D. Graber, F. Ravandi, J. Cortes, M. Andreeff, N. Zhang, K.R. Coombes (2013) Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells, PLoS One, 8: e78453.

H. York, S.M. Kornblau, A.A. Qutub (2012) Network Analysis of Reverse Phase Protein Expression Data: Characterizing Protein Signatures in Acute Myeloid Leukemia Cytogenetic Categories t(8;21) and inv(16), Proteomics 12: 2084-2093. 

S.M. Kornblau, Y.H. Qiu, N. Zhang, N. Singh, S. Faderl, A. Ferrajoli, H. York, A.A. Qutub, K.R. Coombes, D.K. Watson (2011) Abnormal Expression of Friend Leukemia Virus Integration 1 (FLI1) Protein Is an Adverse Prognostic Factor in Acute Myeloid Leukemia, Blood 118: 5604-5612.